E-LIB Suche - Ergebnisse für: Őrsy, Petra

1

Benefits of insulin degludec/liraglutide are maintained eve..:

Janez, Andrej ; Őrsy, Petra ; Stachlewska, Karolina...
Diabetes, Obesity and Metabolism. 22 (2020) 4 - p. 658-668 , 2020

Link: https://doi.org/10.1111/..

2

A greater proportion of participants with type 2 diabetes a..:

Sesti, Giorgio ; Bardtrum, Lars ; Dagdelen, Selcuk...
Diabetes, Obesity and Metabolism. 22 (2020) 5 - p. 873-878 , 2020

Link: https://doi.org/10.1111/..

3

IDegLira improves patient‐reported outcomes while using a s..:

Miller, Eden ; Doshi, Ankur ; Grøn, Randi...
Diabetes, Obesity and Metabolism. 21 (2019) 12 - p. 2643-2650 , 2019

Link: https://doi.org/10.1111/..

4

Lower rates of cardiovascular events and mortality associat..:

Brown‐Frandsen, Kirstine ; Emerson, Scott S. ; McGuire, Darren K....
Diabetes, Obesity and Metabolism. 21 (2019) 6 - p. 1437-1444 , 2019

Link: https://doi.org/10.1111/..

5

Rates of Major Adverse Cardiovascular Events and Mortality ..:

Brown-Frandsen, Kirstine ; Emerson, Scott S. ; Marso, Steven P....
Canadian Journal of Diabetes. 42 (2018) 5 - p. S7-S8 , 2018

Link: https://doi.org/10.1016/..

6

IDegLira Achieved Non-Inferior A1C Reduction, Weight Loss a..:

Miller, Eden ; Jodar, Esteban ; Khunti, Kamlesh...
Canadian Journal of Diabetes. 42 (2018) 5 - p. S48 , 2018

Link: https://doi.org/10.1016/..

7

Erratum: Corrigendum: G12-G13–LARG–mediated signaling in va..:

Wirth, Angela ; Benyó, Zoltán ; Lukasova, Martina...
Nature Medicine. 14 (2008) 2 - p. 222-222 , 2008

Link: https://doi.org/10.1038/..

8

G12-G13–LARG–mediated signaling in vascular smooth muscle i..:

Wirth, Angela ; Benyó, Zoltán ; Lukasova, Martina...
Nature Medicine. 14 (2007) 1 - p. 64-68 , 2007

Link: https://doi.org/10.1038/..

9

Benefits of insulin degludec/liraglutide are maintained eve..:

Janez, Andrej ; Őrsy, Petra ; Stachlewska, Karolina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079143/. , 2020

Link: http://www.ncbi.nlm.nih...

10

A greater proportion of participants with type 2 diabetes a..:

Sesti, Giorgio ; Bardtrum, Lars ; Dagdelen, Selcuk...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187233/. , 2020

Link: http://www.ncbi.nlm.nih...

11

IDegLira improves patient‐reported outcomes while using a s..:

Miller, Eden ; Doshi, Ankur ; Grøn, Randi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899651/. , 2019

Link: http://www.ncbi.nlm.nih...

12

IDegLira improves patient-reported outcomes while using a s..:

Miller, Eden ; Doshi, Ankur ; Grøn, Randi...
Miller, E., Doshi, A., Grøn, R., Jódar, E., Őrsy, P., Ranthe, M. F., Sugimoto, D. Nikolaos Tentolouris, N., Viljoen, A. & Billings, L. K. (2019). IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy. Diabetes, Obesity and Metabolism, 21(12), 2643-2650. https://doi.org/10.1111/dom.13851. , 2019

Link: http://hdl.handle.net/11..

13

Lower rates of cardiovascular events and mortality associat..:

Brown‐Frandsen, Kirstine ; Emerson, Scott S ; McGuire, Darren K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504564/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Elevated systemic TGF-β impairs aortic vasomotor function t..:

Buday, Anna ; Őrsy, Petra ; Godó, Mária...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504387/. , 2010

Link: http://www.ncbi.nlm.nih...